Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00971022 · ClinicalTrials.gov registry record

Discount Generic Prescription Study

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
574
Enrollment target

NCT00971022: Completed study, sponsored by M.D. Anderson Cancer Center.

NCT00971022 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 574 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00971022 has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
574 participants
Enrollment target

Study Summary

The goal of this study is to learn about the factors that influence people to take part in discount generic prescription programs. The primary objective of this study is to identify the factors associated with awareness and utilization of discount generic prescription programs and how two low-income populations in Houston utilize the $4 for a 30-day supply or $10 for a 90-day supply, Generic Prescriptions Program offered by Kroger, Randalls, Target, Walmart, HEB, CVS, and Walgreens.

Interventions

  • BEHAVIORAL Focus Group
  • BEHAVIORAL Survey

Trial Details

FieldValue
Enrollment Target 574 participants
Start Date 2009-08
Est. Completion 2011-05

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00971022

The ClinicalTrials.gov registry entry for NCT00971022 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 574 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Focus Group is the first listed.

NCT00971022 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00971022 about?

NCT00971022 is a clinical study titled "Discount Generic Prescription Study". The goal of this study is to learn about the factors that influence people to take part in discount generic prescription programs. The primary objective of this study is to identify the factors associated with awareness and utilization of discount generic prescription programs and how two low-incom...

What is the current status of trial NCT00971022?

This trial is currently completed. The enrollment target is 574 participants. The study started on 2009-08. Estimated completion is 2011-05.

What interventions are being tested in trial NCT00971022?

The interventions under investigation include: Focus Group (BEHAVIORAL), Survey (BEHAVIORAL).

Who is sponsoring clinical trial NCT00971022?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.